Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Hair loss in a child was an early sign of Crohn's disease.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Dengue fever can cause hair loss that may lead to serious psychological issues like Body Dysmorphic Disorder in young women.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

People with chronic hair loss often have lower Vitamin B12 levels.

A girl lost her hair due to being given the wrong medication because of a pharmacy's computer error.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

The food supplement improved hair growth and strength in people with a certain type of hair loss and had no major side effects.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.